XML 25 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Net loss $ (12,047,796) $ (19,231,488)
Available for sale securities - net unrealized loss (486) (1,329)
Total other comprehensive loss (486) (1,329)
Comprehensive loss (12,048,282) (19,232,817)
Comprehensive loss attributable to noncontrolling interests (66,879) (44,592)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (11,981,403) $ (19,188,225)